CCC-010.3	154	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	41	0.0000000000000000000000000
CCC-009.8	167	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	38	0.0000000000000000000000000
CCC-011.2	194	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	38	0.0000000000000000000000000
CCC-023.1	131	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	34	0.0000000000000000000000000
CCC-010.3	154	0_HALLMARK_COAGULATION	125	42	0.0000000000000000000000000
CCC-018.6	223	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	37	0.0000000000000000000000000
CCC-001.3	181	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	35	0.0000000000000000000000000
CCC-047.8	330	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	41	0.0000000000000000000000000
CCC-020.1	118	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	31	0.0000000000000000000000000
CCC-026a.2	94	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	29	0.0000000000000000000000000
CCC-024.5	296	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	39	0.0000000000000000000000000
CCC-019.10	149	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	32	0.0000000000000000000000000
CCC-023.1	131	0_HALLMARK_COAGULATION	125	37	0.0000000000000000000000000
CCC-030.1	192	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	34	0.0000000000000000000000000
CCC-011.2	194	0_HALLMARK_COAGULATION	125	41	0.0000000000000000000000000
CCC-013.8	242	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	35	0.0000000000000000000000000
CCC-026.4	163	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	31	0.0000000000000000000000000
CCC-026a.2	94	0_HALLMARK_COAGULATION	125	31	0.0000000000000000000000000
CCC-014.4	251	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	34	0.0000000000000000000000000
CCC-025.3	260	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	34	0.0000000000000000000000000
CCC-004.6	237	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	33	0.0000000000000000000000000
CCC-016.8	265	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	34	0.0000000000000000000000000
CCC-003.4	381	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	37	0.0000000000000000000000000
CCC-009.8	167	0_HALLMARK_COAGULATION	125	35	0.0000000000000000000000000
CCC-013.8	242	0_HALLMARK_COAGULATION	125	38	0.0000000000000000000000000
CCC-014.4	251	0_HALLMARK_COAGULATION	125	38	0.0000000000000000000000000
CCC-024.5	296	0_HALLMARK_COAGULATION	125	40	0.0000000000000000000000000
CCC-030.1	192	0_HALLMARK_COAGULATION	125	34	0.0000000000000000000000000
CCC-026.4	163	0_HALLMARK_COAGULATION	125	32	0.0000000000000000000000000
CCC-001.3	181	0_HALLMARK_COAGULATION	125	33	0.0000000000000000000000001
CCC-018.6	223	0_HALLMARK_COAGULATION	125	35	0.0000000000000000000000003
CCC-047.8	330	0_HALLMARK_COAGULATION	125	40	0.0000000000000000000000005
CCC-020.1	118	0_HALLMARK_COAGULATION	125	28	0.0000000000000000000000007
CCC-019.10	149	0_HALLMARK_COAGULATION	125	30	0.0000000000000000000000014
CCC-031.5	111	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	22	0.0000000000000000000000248
CCC-004.6	237	0_HALLMARK_COAGULATION	125	34	0.0000000000000000000000386
CCC-025.3	260	0_HALLMARK_COAGULATION	125	34	0.0000000000000000000009091
CCC-003.4	381	0_HALLMARK_COAGULATION	125	38	0.0000000000000000000201791
CCC-010.3	154	2_EXTRACELLULAR_REGION	346	39	0.0000000000000000002360006
CCC-016.8	265	0_HALLMARK_COAGULATION	125	32	0.0000000000000000003493917
CCC-009.8	167	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	17	0.0000000000000000010849055
CCC-009.8	167	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	17	0.0000000000000000040931680
CCC-009.8	167	2_SERINE_HYDROLASE_ACTIVITY	36	17	0.0000000000000000076388681
CCC-023.1	131	2_EXTRACELLULAR_REGION	346	34	0.0000000000000000607772335
CCC-010.3	154	2_EXTRACELLULAR_REGION_PART	269	31	0.0000000000000051909235359
CCC-023.1	131	2_EXTRACELLULAR_REGION_PART	269	28	0.0000000000000458944014020
CCC-001.3	181	0_HALLMARK_XENOBIOTIC_METABOLISM	134	24	0.0000000000000718265679230
CCC-024.5	296	0_HALLMARK_XENOBIOTIC_METABOLISM	134	29	0.0000000000001150072457407
CCC-023.1	131	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	13	0.0000000000002925067032530
CCC-010.3	154	2_WOUND_HEALING	46	15	0.0000000000004277621289108
CCC-001.3	181	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	14	0.0000000000005451421979176
CCC-023.1	131	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	13	0.0000000000007360151009910
CCC-010.3	154	2_BLOOD_COAGULATION	39	14	0.0000000000009229174186088
CCC-010.3	154	2_COAGULATION	39	14	0.0000000000009229174186088
CCC-023.1	131	2_SERINE_HYDROLASE_ACTIVITY	36	13	0.0000000000011386337903242
CCC-001.3	181	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	14	0.0000000000014939307649883
CCC-019.10	149	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	13	0.0000000000016244062258317
CCC-009.8	167	2_ENDOPEPTIDASE_ACTIVITY	91	19	0.0000000000018276140706287
CCC-023.1	131	2_EXTRACELLULAR_SPACE	192	23	0.0000000000020132819806020
CCC-033.5	38	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0000000000023872361654351
CCC-001.3	181	2_SERINE_HYDROLASE_ACTIVITY	36	14	0.0000000000024042053558862
CCC-019.10	149	2_EXTRACELLULAR_REGION	346	31	0.0000000000026527320261397
CCC-019.9	21	2_MYOFIBRIL	17	7	0.0000000000028355865406973
CCC-003.6	7	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	8	5	0.0000000000031696082948446
CCC-025.3	260	0_HALLMARK_XENOBIOTIC_METABOLISM	134	26	0.0000000000035001814515097
CCC-019.10	149	2_EXTRACELLULAR_SPACE	192	24	0.0000000000035659308420139
CCC-020.1	118	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	12	0.0000000000039185357139606
CCC-019.10	149	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	13	0.0000000000040727566632081
CCC-020.1	118	0_HALLMARK_XENOBIOTIC_METABOLISM	134	19	0.0000000000044709080186565
CCC-019.10	149	2_SERINE_HYDROLASE_ACTIVITY	36	13	0.0000000000062893723776238
CCC-031.5	111	0_HALLMARK_COAGULATION	125	18	0.0000000000063625893596784
CCC-010.3	154	2_HEMOSTASIS	44	14	0.0000000000065591470770549
CCC-020.1	118	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	12	0.0000000000090252573705761
CCC-019.9	21	2_CONTRACTILE_FIBER_PART	20	7	0.0000000000112587123777535
CCC-003.4	381	0_HALLMARK_XENOBIOTIC_METABOLISM	134	30	0.0000000000127335815259761
CCC-020.1	118	2_SERINE_HYDROLASE_ACTIVITY	36	12	0.0000000000133973929060233
CCC-026a.2	94	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000000000141688939186404
CCC-047.8	330	0_HALLMARK_XENOBIOTIC_METABOLISM	134	28	0.0000000000176232713446342
CCC-011.2	194	2_EXTRACELLULAR_REGION	346	34	0.0000000000242777785153674
CCC-019.9	21	2_CONTRACTILE_FIBER	22	7	0.0000000000247048676248942
CCC-026a.2	94	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000000000300542784573288
CCC-026.4	163	2_EXTRACELLULAR_REGION	346	31	0.0000000000367325056309680
CCC-026a.2	94	2_EXTRACELLULAR_REGION	346	24	0.0000000000367701916924234
CCC-026a.2	94	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000000000429289065769904
CCC-023.1	131	2_WOUND_HEALING	46	13	0.0000000000446112094375817
CCC-030.1	192	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	13	0.0000000000455482919766152
CCC-011.2	194	0_HALLMARK_XENOBIOTIC_METABOLISM	134	22	0.0000000000466585790237744
CCC-026a.2	94	2_EXTRACELLULAR_SPACE	192	19	0.0000000000467651668988076
CCC-020.1	118	2_LIPID_METABOLIC_PROCESS	174	20	0.0000000000488201911891994
CCC-009.8	167	0_HALLMARK_COMPLEMENT	176	23	0.0000000000684502585145195
CCC-010.3	154	2_EXTRACELLULAR_SPACE	192	23	0.0000000000768120831778721
CCC-019.9	21	2_SARCOMERE	12	6	0.0000000000852122535908388
CCC-010.3	154	2_REGULATION_OF_BODY_FLUID_LEVELS	52	14	0.0000000000902653284052206
CCC-030.1	192	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	13	0.0000000001132237358304993
CCC-019.10	149	2_EXTRACELLULAR_REGION_PART	269	26	0.0000000001141302204837349
CCC-009.8	167	2_PEPTIDASE_ACTIVITY	129	20	0.0000000001288199105661074
CCC-023.1	131	2_ENDOPEPTIDASE_ACTIVITY	91	16	0.0000000001345188179026422
CCC-013.8	242	2_EXTRACELLULAR_REGION	346	37	0.0000000001366877535562548
CCC-026.4	163	2_EXTRACELLULAR_REGION_PART	269	27	0.0000000001381291233663131
CCC-023.1	131	2_BLOOD_COAGULATION	39	12	0.0000000001457158663882035
CCC-023.1	131	2_COAGULATION	39	12	0.0000000001457158663882035
CCC-019.9	21	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	7	0.0000000001701863961681293
CCC-030.1	192	2_SERINE_HYDROLASE_ACTIVITY	36	13	0.0000000001740974138930808
CCC-020.1	118	2_HEMOSTASIS	44	12	0.0000000002076674581642985
CCC-023.1	131	2_PEPTIDASE_ACTIVITY	129	18	0.0000000002238490032507305
CCC-009.8	167	0_HALLMARK_XENOBIOTIC_METABOLISM	134	20	0.0000000002717005110346131
CCC-026a.2	94	2_LIPID_TRANSPORT	21	9	0.0000000002909959189805863
CCC-030.1	192	2_WOUND_HEALING	46	14	0.0000000002922128648233087
CCC-011.2	194	2_RESPONSE_TO_WOUNDING	163	23	0.0000000003351679751171191
CCC-011.2	194	2_WOUND_HEALING	46	14	0.0000000003373932693956835
CCC-020.1	118	2_WOUND_HEALING	46	12	0.0000000003752165075143859
CCC-030.1	192	0_HALLMARK_XENOBIOTIC_METABOLISM	134	21	0.0000000003928736049391888
CCC-024.5	296	2_WOUND_HEALING	46	16	0.0000000004135351453898628
CCC-024.5	296	2_BLOOD_COAGULATION	39	15	0.0000000004174094783619799
CCC-024.5	296	2_COAGULATION	39	15	0.0000000004174094783619799
CCC-023.1	131	0_HALLMARK_XENOBIOTIC_METABOLISM	134	18	0.0000000004399084903277323
CCC-009.8	167	2_EXTRACELLULAR_REGION	346	30	0.0000000004769113907330503
CCC-030.1	192	2_BLOOD_COAGULATION	39	13	0.0000000005801737809668688
CCC-030.1	192	2_COAGULATION	39	13	0.0000000005801737809668688
CCC-030.1	192	2_EXTRACELLULAR_REGION	346	32	0.0000000006421516967132362
CCC-011.2	194	2_BLOOD_COAGULATION	39	13	0.0000000006632939193406583
CCC-011.2	194	2_COAGULATION	39	13	0.0000000006632939193406583
CCC-010.3	154	0_HALLMARK_XENOBIOTIC_METABOLISM	134	19	0.0000000006700855342042266
CCC-001.3	181	2_EXTRACELLULAR_REGION	346	31	0.0000000007168994001179823
CCC-023.1	131	2_HEMOSTASIS	44	12	0.0000000007411152145343280
CCC-026a.2	94	2_WOUND_HEALING	46	11	0.0000000008790227879680679
CCC-023.1	131	2_RESPONSE_TO_WOUNDING	163	19	0.0000000012474722148374194
CCC-011.2	194	2_EXTRACELLULAR_SPACE	192	24	0.0000000014723851568965917
CCC-014.4	251	2_EXTRACELLULAR_SPACE	192	27	0.0000000015079237775940929
CCC-020.1	118	2_BLOOD_COAGULATION	39	11	0.0000000015165885797654876
CCC-020.1	118	2_COAGULATION	39	11	0.0000000015165885797654876
CCC-011.2	194	2_EXTRACELLULAR_REGION_PART	269	28	0.0000000016143362043989116
CCC-020.1	118	2_REGULATION_OF_BODY_FLUID_LEVELS	52	12	0.0000000018693241553691942
CCC-001.3	181	2_EXTRACELLULAR_REGION_PART	269	27	0.0000000018812178845856609
CCC-026.4	163	0_HALLMARK_XENOBIOTIC_METABOLISM	134	19	0.0000000018954246436950096
CCC-026a.2	94	2_EXTRACELLULAR_REGION_PART	269	20	0.0000000020953189992882941
CCC-018.6	223	2_WOUND_HEALING	46	14	0.0000000023029210988817909
CCC-047.8	330	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	14	0.0000000023243039111100575
CCC-030.1	192	2_RESPONSE_TO_WOUNDING	163	22	0.0000000023593719165547975
CCC-013.8	242	2_EXTRACELLULAR_REGION_PART	269	31	0.0000000023807493081445078
CCC-010.3	154	2_RESPONSE_TO_WOUNDING	163	20	0.0000000025098172978014088
CCC-001.3	181	2_EXTRACELLULAR_SPACE	192	23	0.0000000025758015407592724
CCC-024.5	296	2_HEMOSTASIS	44	15	0.0000000033133441145040398
CCC-030.1	192	2_HEMOSTASIS	44	13	0.0000000033928935635386480
CCC-013.8	242	2_HEMOSTASIS	44	14	0.0000000035285974580677390
CCC-010.3	154	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000000036205183737079717
CCC-024.5	296	2_EXTRACELLULAR_REGION	346	39	0.0000000036981079606471391
CCC-011.2	194	2_HEMOSTASIS	44	13	0.0000000038751115416944870
CCC-009.8	167	2_EXTRACELLULAR_SPACE	192	22	0.0000000038911924730360197
CCC-018.6	223	2_BLOOD_COAGULATION	39	13	0.0000000039727869434264645
CCC-018.6	223	2_COAGULATION	39	13	0.0000000039727869434264645
CCC-031.5	111	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	10	0.0000000041422218175234808
CCC-013.8	242	2_EXTRACELLULAR_SPACE	192	26	0.0000000042653704954235433
CCC-013.8	242	0_HALLMARK_XENOBIOTIC_METABOLISM	134	22	0.0000000044589199838211319
CCC-022.1	71	0_HALLMARK_MYC_TARGETS_V1	178	15	0.0000000045624759082023528
CCC-026a.2	94	2_BLOOD_COAGULATION	39	10	0.0000000049371188547230802
CCC-026a.2	94	2_COAGULATION	39	10	0.0000000049371188547230802
CCC-047.4	6	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	8	4	0.0000000053445256893790028
CCC-047.8	330	2_EXTRACELLULAR_SPACE	192	30	0.0000000059531975974261809
CCC-047.8	330	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	14	0.0000000061805916183638750
CCC-023.1	131	2_REGULATION_OF_BODY_FLUID_LEVELS	52	12	0.0000000066029913574258470
CCC-047.8	330	2_EXTRACELLULAR_REGION	346	41	0.0000000067544191764255247
CCC-026.4	163	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000000067702509873895374
CCC-013.8	242	2_WOUND_HEALING	46	14	0.0000000070347560990190107
CCC-010.3	154	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000000075897927647841128
CCC-031.5	111	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	10	0.0000000080562853176787152
CCC-010.3	154	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	24	0.0000000085318923929538724
CCC-047.8	330	2_SERINE_HYDROLASE_ACTIVITY	36	14	0.0000000097978501263237157
CCC-014.4	251	2_EXTRACELLULAR_REGION	346	35	0.0000000104626913812046814
CCC-010.3	154	0_HALLMARK_COMPLEMENT	176	20	0.0000000106895870499911210
CCC-010.3	154	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000000107775017652191652
CCC-031.5	111	2_SERINE_HYDROLASE_ACTIVITY	36	10	0.0000000110462992269525548
CCC-013.8	242	2_BLOOD_COAGULATION	39	13	0.0000000112605887621844460
CCC-013.8	242	2_COAGULATION	39	13	0.0000000112605887621844460
CCC-024.5	296	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	13	0.0000000119071435788487053
CCC-026.4	163	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000000141675758362683646
CCC-004.6	237	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	12	0.0000000177001162737460239
CCC-026a.2	94	2_HEMOSTASIS	44	10	0.0000000185014544311476818
CCC-026.4	163	2_EXTRACELLULAR_SPACE	192	21	0.0000000196316058241515696
CCC-026.4	163	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000000201001643923512569
CCC-001.3	181	2_ENDOPEPTIDASE_ACTIVITY	91	16	0.0000000213064780695894071
CCC-018.6	223	2_HEMOSTASIS	44	13	0.0000000228757177103558051
CCC-020.1	118	2_RESPONSE_TO_WOUNDING	163	17	0.0000000241454474495576635
CCC-030.1	192	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	16	0.0000000256012660376507179
CCC-024.5	296	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	13	0.0000000289870857291152183
CCC-018.6	223	2_EXTRACELLULAR_SPACE	192	24	0.0000000306778381833802704
CCC-003.4	381	0_HALLMARK_MYC_TARGETS_V1	178	30	0.0000000315081184812043651
CCC-018.6	223	0_HALLMARK_COMPLEMENT	176	23	0.0000000329114343856693032
CCC-014.4	251	2_EXTRACELLULAR_REGION_PART	269	30	0.0000000336727028924364849
CCC-016.8	265	2_EXTRACELLULAR_SPACE	192	26	0.0000000343222470314060135
CCC-014.4	251	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	12	0.0000000347768455248851163
CCC-030.1	192	2_REGULATION_OF_BODY_FLUID_LEVELS	52	13	0.0000000359995531587652992
CCC-011.2	194	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	26	0.0000000366980041630382749
CCC-004.6	237	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	12	0.0000000398160086403212267
CCC-011.2	194	2_REGULATION_OF_BODY_FLUID_LEVELS	52	13	0.0000000410503880861726371
CCC-018.6	223	2_EXTRACELLULAR_REGION	346	32	0.0000000411056992294856613
CCC-024.5	296	2_SERINE_HYDROLASE_ACTIVITY	36	13	0.0000000441089104564377186
CCC-026.4	163	2_LIPID_TRANSPORT	21	9	0.0000000451561682297707082
CCC-013.8	242	2_REGULATION_OF_BODY_FLUID_LEVELS	52	14	0.0000000452425592813173553
CCC-019.10	149	0_HALLMARK_XENOBIOTIC_METABOLISM	134	17	0.0000000453812705094007651
CCC-011.2	194	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000000454508779354840766
CCC-030.1	192	2_EXTRACELLULAR_REGION_PART	269	26	0.0000000481878274195698251
CCC-024.5	296	2_REGULATION_OF_BODY_FLUID_LEVELS	52	15	0.0000000514956588266567857
CCC-025.3	260	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	12	0.0000000525718070959228058
CCC-004.6	237	2_SERINE_HYDROLASE_ACTIVITY	36	12	0.0000000584106748725058565
CCC-001.3	181	2_WOUND_HEALING	46	12	0.0000000632539708584055711
CCC-013.8	242	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	33	0.0000000688917008301681137
CCC-014.4	251	0_HALLMARK_MYC_TARGETS_V1	178	24	0.0000000744051764148200129
CCC-014.4	251	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	12	0.0000000780116992316448671
CCC-010.3	154	0_HALLMARK_ANGIOGENESIS	32	10	0.0000000791385433770927167
CCC-010.3	154	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	19	0.0000000840198754808952966
CCC-009.8	167	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	27	0.0000000870568804987457691
CCC-047.8	330	2_EXTRACELLULAR_REGION_PART	269	34	0.0000000909672470576035270
CCC-011.2	194	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000000945329069919118250
CCC-024.5	296	2_EXTRACELLULAR_REGION_PART	269	32	0.0000001004238106639735222
CCC-026a.2	94	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0000001105316470229574020
CCC-023.1	131	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	21	0.0000001119175094540667177
CCC-014.4	251	2_SERINE_HYDROLASE_ACTIVITY	36	12	0.0000001142847832183879779
CCC-025.3	260	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	12	0.0000001177179400829349047
CCC-011.2	194	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000001337095319938948452
CCC-020.1	118	2_LIPID_TRANSPORT	21	8	0.0000001399508916244286474
CCC-001.3	181	2_BLOOD_COAGULATION	39	11	0.0000001672694531633678427
CCC-001.3	181	2_COAGULATION	39	11	0.0000001672694531633678427
CCC-025.3	260	2_SERINE_HYDROLASE_ACTIVITY	36	12	0.0000001722985248197584271
CCC-004.6	237	0_HALLMARK_XENOBIOTIC_METABOLISM	134	20	0.0000001880901473316628867
CCC-016.8	265	2_HEMOSTASIS	44	13	0.0000002003235777183863394
CCC-018.6	223	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000002052406512023899557
CCC-011.2	194	2_LIPID_TRANSPORT	21	9	0.0000002164928283906434590
CCC-018.6	223	2_REGULATION_OF_BODY_FLUID_LEVELS	52	13	0.0000002367763979579195785
CCC-014.4	251	2_RESPONSE_TO_STRESS	427	37	0.0000002393872669826959777
CCC-013.8	242	2_RESPONSE_TO_WOUNDING	163	22	0.0000002413176042380270415
CCC-026.4	163	0_HALLMARK_COMPLEMENT	176	19	0.0000002527836794812016102
CCC-018.6	223	2_EXTRACELLULAR_REGION_PART	269	27	0.0000002709281024682600910
CCC-052.2	14	1_KEGG_LINOLEIC_ACID_METABOLISM	25	5	0.0000002823100109450966263
CCC-003.4	381	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	13	0.0000002833670261300701020
CCC-010.3	154	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0000003160606523582144903
CCC-030.1	192	1_KEGG_RETINOL_METABOLISM	39	11	0.0000003161785987973459542
CCC-023.1	131	2_LIPID_TRANSPORT	21	8	0.0000003256627465588621487
CCC-020.1	118	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	22	0.0000003340273915044281241
CCC-014.4	251	0_HALLMARK_COMPLEMENT	176	23	0.0000003664336388401722926
CCC-019.9	21	2_STRUCTURAL_MOLECULE_ACTIVITY	206	9	0.0000003705110321109836948
CCC-016.8	265	2_WOUND_HEALING	46	13	0.0000003734664738567162667
CCC-001.3	181	2_RESPONSE_TO_WOUNDING	163	19	0.0000004115217595035793479
CCC-023.1	131	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0000004131104517181247694
CCC-010.3	154	2_PEPTIDASE_ACTIVITY	129	16	0.0000004199260877527144213
CCC-026a.1	7	2_MYOFIBRIL	17	4	0.0000004228863049163048204
CCC-010.3	154	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	25	0.0000004236857570444147201
CCC-018.6	223	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000004244439378308443959
CCC-047.8	330	2_WOUND_HEALING	46	14	0.0000004508324981586937699
CCC-023.1	131	0_HALLMARK_COMPLEMENT	176	17	0.0000004520086830707430496
CCC-030.1	192	2_EXTRACELLULAR_SPACE	192	21	0.0000004528656780341365892
CCC-030.1	192	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	28	0.0000004592172550271847288
CCC-013.8	242	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000004938243387009359871
CCC-009.8	167	2_WOUND_HEALING	46	11	0.0000004995383911452627342
CCC-024.5	296	2_ENDOPEPTIDASE_ACTIVITY	91	18	0.0000005114514724611812063
CCC-001.3	181	2_PEPTIDASE_ACTIVITY	129	17	0.0000005494083105662951579
CCC-047.8	330	2_BLOOD_COAGULATION	39	13	0.0000005506594010851538963
CCC-047.8	330	2_COAGULATION	39	13	0.0000005506594010851538963
CCC-030.1	192	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	20	0.0000005625553275484399290
CCC-018.6	223	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000005986296000325003225
CCC-026a.2	94	2_PEPTIDASE_ACTIVITY	129	13	0.0000006202561615344445641
CCC-016.8	265	2_BLOOD_COAGULATION	39	12	0.0000006232349626205558219
CCC-016.8	265	2_COAGULATION	39	12	0.0000006232349626205558219
CCC-025.3	260	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0000006600215319687062640
CCC-026.4	163	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0000006760457899917227378
CCC-003.4	381	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	13	0.0000006780806581525198749
CCC-037.2	8	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	6	0.0000006956219950037680412
CCC-001.3	181	2_HEMOSTASIS	44	11	0.0000007042966945335696101
CCC-018.6	223	2_LIPID_TRANSPORT	21	9	0.0000007517653951545906983
CCC-024.5	296	2_PEPTIDASE_ACTIVITY	129	21	0.0000007519129213061585987
CCC-018.6	223	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	30	0.0000007786035086712800333
CCC-030.1	192	2_RESPONSE_TO_STRESS	427	31	0.0000008058626003646060197
CCC-031.5	111	2_BLOOD_COAGULATION	39	9	0.0000008196634896954653740
CCC-031.5	111	2_COAGULATION	39	9	0.0000008196634896954653740
CCC-026a.1	7	2_CONTRACTILE_FIBER_PART	20	4	0.0000008602188231485019501
CCC-019.10	149	2_LIPID_TRANSPORT	21	8	0.0000009163140946173093589
CCC-014.4	251	0_HALLMARK_E2F_TARGETS	169	22	0.0000009946180106087158628
CCC-026a.2	94	0_HALLMARK_XENOBIOTIC_METABOLISM	134	13	0.0000010005559963578790848
CCC-013.8	242	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000010174186157924652512
CCC-003.4	381	2_SERINE_HYDROLASE_ACTIVITY	36	13	0.0000010229922617380119453
CCC-026a.2	94	2_RESPONSE_TO_WOUNDING	163	14	0.0000010548067382624700259
CCC-026a.1	7	2_STRUCTURAL_MOLECULE_ACTIVITY	206	6	0.0000011613745239064561453
CCC-009.8	167	2_PROTEASE_INHIBITOR_ACTIVITY	28	9	0.0000011878884850396082547
CCC-026a.1	7	2_CONTRACTILE_FIBER	22	4	0.0000012981008823991307460
CCC-016.8	265	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	11	0.0000013011217622953193930
CCC-020.1	118	1_KEGG_RETINOL_METABOLISM	39	9	0.0000014213178054832716334
CCC-013.8	242	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000014322636130336778898
CCC-052.5	91	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	10	0.0000014961225360551536706
CCC-001.3	181	0_HALLMARK_COMPLEMENT	176	19	0.0000015496241403302543988
CCC-009.8	167	2_BLOOD_COAGULATION	39	10	0.0000015698925511312365055
CCC-009.8	167	2_COAGULATION	39	10	0.0000015698925511312365055
CCC-026.4	163	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	18	0.0000017597235097651059163
CCC-019.10	149	2_HEMOSTASIS	44	10	0.0000018624151769799154176
CCC-020.1	118	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	14	0.0000018676153631044152914
CCC-020.1	118	2_ENDOPEPTIDASE_ACTIVITY	91	12	0.0000019016307154564017486
CCC-009.8	167	2_ENZYME_INHIBITOR_ACTIVITY	96	14	0.0000019373668557400467732
CCC-016.8	265	2_REGULATION_OF_BODY_FLUID_LEVELS	52	13	0.0000020048544040507582875
CCC-024.5	296	2_RESPONSE_TO_WOUNDING	163	23	0.0000020352746842229715606
CCC-024.5	296	2_EXTRACELLULAR_SPACE	192	25	0.0000021228301300641941448
CCC-026a.2	94	2_ENDOPEPTIDASE_ACTIVITY	91	11	0.0000021645179664398201000
CCC-026a.2	94	2_LIPID_HOMEOSTASIS	13	6	0.0000022633357851988940293
CCC-009.8	167	2_LIPID_TRANSPORT	21	8	0.0000022786713871338561509
CCC-019.10	149	2_PEPTIDASE_ACTIVITY	129	15	0.0000024735262997800257749
CCC-019.10	149	2_ENDOPEPTIDASE_ACTIVITY	91	13	0.0000024845457650190450990
CCC-031.5	111	2_HEMOSTASIS	44	9	0.0000026113134534910583320
CCC-016.8	265	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	11	0.0000026685151735905279008
CCC-020.1	118	2_EXTRACELLULAR_SPACE	192	16	0.0000029015972759915861644
CCC-016.8	265	2_EXTRACELLULAR_REGION_PART	269	28	0.0000029237079795963064243
CCC-009.8	167	2_EXTRACELLULAR_REGION_PART	269	22	0.0000029441166531872917533
CCC-019.10	149	2_WOUND_HEALING	46	10	0.0000029783566420989823554
CCC-047.8	330	2_HEMOSTASIS	44	13	0.0000030048162746231273773
CCC-022.1	71	2_NUCLEUS	1110	28	0.0000033735360812415004121
CCC-030.1	192	2_LIPID_METABOLIC_PROCESS	174	19	0.0000034772524980242086193
CCC-026a.1	7	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	4	0.0000036278947792151237511
CCC-030.1	192	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	11	0.0000036341488650674574718
CCC-016.8	265	2_SERINE_HYDROLASE_ACTIVITY	36	11	0.0000037480524506231111535
CCC-004.6	237	2_EXTRACELLULAR_REGION	346	30	0.0000039571789374352327697
CCC-031.5	111	2_WOUND_HEALING	46	9	0.0000039795877533212185284
CCC-011.2	194	2_LIPID_METABOLIC_PROCESS	174	19	0.0000041419435855341484243
CCC-001.3	181	2_LIPID_TRANSPORT	21	8	0.0000043214702313564976928
CCC-023.1	131	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	5	0.0000047616799542016637197
CCC-001.3	181	2_REGULATION_OF_BODY_FLUID_LEVELS	52	11	0.0000048558390519541178655
CCC-011.2	194	0_HALLMARK_COMPLEMENT	176	19	0.0000050252799104848426667
CCC-014.4	251	2_DNA_METABOLIC_PROCESS	218	24	0.0000051099227425342885840
CCC-004.6	237	2_EXTRACELLULAR_REGION_PART	269	26	0.0000051918214168385793135
CCC-030.1	192	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	23	0.0000052652332015008095569
CCC-004.6	237	0_HALLMARK_MYC_TARGETS_V1	178	21	0.0000053971596254082090455
CCC-009.8	167	2_HEMOSTASIS	44	10	0.0000056781440236322584561
CCC-030.1	192	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0000058462501443469589118
CCC-009.8	167	2_RESPONSE_TO_WOUNDING	163	17	0.0000061851843363285289484
CCC-019.10	149	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	23	0.0000062252724775552228278
CCC-030.1	192	2_LIPID_TRANSPORT	21	8	0.0000068965648390086848403
CCC-026.4	163	2_WOUND_HEALING	46	10	0.0000071516909106800301548
CCC-020.1	118	0_HALLMARK_COMPLEMENT	176	15	0.0000071527936787461747050
CCC-013.8	242	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	15	0.0000074861458630797128128
CCC-016.8	265	2_RESPONSE_TO_WOUNDING	163	21	0.0000080483443540150054484
CCC-018.6	223	1_KEGG_PRION_DISEASES	35	10	0.0000081221417702353618993
CCC-031.5	111	0_HALLMARK_XENOBIOTIC_METABOLISM	134	13	0.0000081329225337457006890
CCC-026.4	163	2_PEPTIDASE_ACTIVITY	129	15	0.0000086418528004006831071
CCC-052.2	14	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	5	0.0000089333417404259956191
CCC-052.2	14	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	5	0.0000089333417404259956191
CCC-025.3	260	2_EXTRACELLULAR_REGION	346	31	0.0000091855671209450498379
CCC-024.5	296	2_LIPID_TRANSPORT	21	9	0.0000091954470951038465900
CCC-020.1	118	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	9	0.0000102393676010719946861
CCC-019.10	149	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0000106614722406910234577
CCC-020.1	118	2_PEPTIDASE_ACTIVITY	129	13	0.0000108647457327758455566
CCC-030.1	192	2_PEPTIDASE_ACTIVITY	129	16	0.0000109190739469889384167
CCC-019.10	149	2_BLOOD_COAGULATION	39	9	0.0000113333194551764449400
CCC-019.10	149	2_COAGULATION	39	9	0.0000113333194551764449400
CCC-026.4	163	2_LIPID_METABOLIC_PROCESS	174	17	0.0000116043166538820748736
CCC-037.3	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	6	0.0000123741305625540615513
CCC-031.5	111	2_REGULATION_OF_BODY_FLUID_LEVELS	52	9	0.0000125327645404148786483
CCC-016.8	265	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	31	0.0000126736939803545672147
CCC-009.8	167	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	7	0.0000134644465779568974330
CCC-018.6	223	2_PEPTIDASE_ACTIVITY	129	17	0.0000137257040831155219815
CCC-020.1	118	2_EXTRACELLULAR_REGION	346	20	0.0000141968092532643629718
CCC-016.8	265	2_EXTRACELLULAR_REGION	346	31	0.0000145515220038884535132
CCC-047.8	330	0_HALLMARK_COMPLEMENT	176	24	0.0000156057133785975448684
CCC-035.2	59	2_ENDOPLASMIC_RETICULUM	177	11	0.0000158468004367194798855
CCC-019.10	149	2_CHEMICAL_HOMEOSTASIS	126	14	0.0000163031790477047389761
CCC-010.3	154	2_PROTEASE_INHIBITOR_ACTIVITY	28	8	0.0000165460823279622173758
CCC-047.8	330	2_RESPONSE_TO_WOUNDING	163	23	0.0000165478114276135832939
CCC-023.1	131	2_LIPID_HOMEOSTASIS	13	6	0.0000169654008045357544514
CCC-013.8	242	2_RESPONSE_TO_STRESS	427	33	0.0000184421796746719850863
CCC-037.3	10	1_KEGG_ECM_RECEPTOR_INTERACTION	84	5	0.0000202584115769282612266
CCC-004.6	237	2_WOUND_HEALING	46	11	0.0000204059920917001821645
CCC-004.6	237	2_EXTRACELLULAR_SPACE	192	21	0.0000212599011092196898997
CCC-016.8	265	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	12	0.0000237604436080243269737
CCC-023.2	39	2_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION_AND_BIOGENESIS	113	8	0.0000249081772431977588474
CCC-026.4	163	1_KEGG_RETINOL_METABOLISM	39	9	0.0000249537901338923182384
CCC-026.4	163	2_BLOOD_COAGULATION	39	9	0.0000249537901338923182384
CCC-026.4	163	2_COAGULATION	39	9	0.0000249537901338923182384
CCC-023.1	131	2_LIPID_METABOLIC_PROCESS	174	15	0.0000261896836027932613568
CCC-030.1	192	0_HALLMARK_COMPLEMENT	176	18	0.0000268400069364151844817
CCC-047.8	330	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	13	0.0000285421102536733231093
CCC-047.8	330	2_REGULATION_OF_BODY_FLUID_LEVELS	52	13	0.0000285421102536733231093
CCC-026a.2	94	0_HALLMARK_COMPLEMENT	176	13	0.0000285939166872855975035
CCC-024.5	296	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	12	0.0000307168103944219060423
CCC-024.5	296	1_KEGG_RETINOL_METABOLISM	39	11	0.0000307346826953767054752
CCC-026.4	163	2_RESPONSE_TO_WOUNDING	163	16	0.0000309159371788272503679
CCC-003.4	381	2_WOUND_HEALING	46	13	0.0000311878631999136114576
CCC-009.8	167	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0000320533449741378309995
CCC-010.3	154	2_LIPID_METABOLIC_PROCESS	174	16	0.0000348534089223608570729
CCC-003.6	7	1_KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	9	3	0.0000352919467884678145133
CCC-003.6	7	2_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_NOT_PEPTIDEBONDSIN_CYCLIC_AMIDINES	9	3	0.0000352919467884678145133
CCC-004.6	237	2_LIPID_TRANSPORT	21	8	0.0000361568302773652156391
CCC-025.3	260	2_EXTRACELLULAR_REGION_PART	269	26	0.0000365805096745213225167
CCC-019.10	149	2_LIPID_HOMEOSTASIS	13	6	0.0000368300181110417171196
CCC-014.4	251	2_WOUND_HEALING	46	11	0.0000370395579076064951937
CCC-004.6	237	2_RESPONSE_TO_WOUNDING	163	19	0.0000382393085425931922305
CCC-003.4	381	2_BLOOD_COAGULATION	39	12	0.0000383592466496400667851
CCC-003.4	381	2_COAGULATION	39	12	0.0000383592466496400667851
CCC-018.6	223	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0000400560376116000364691
CCC-020.1	118	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	17	0.0000410711194114378845836
CCC-016.8	265	1_KEGG_PRION_DISEASES	35	10	0.0000425182578743556939690
CCC-013.8	242	2_LIPID_TRANSPORT	21	8	0.0000425696264526864969618
CCC-010.3	154	2_LIPID_TRANSPORT	21	7	0.0000432727143023700622487
CCC-033.5	38	0_HALLMARK_COAGULATION	125	8	0.0000444172094735156123310
CCC-004.6	237	2_BLOOD_COAGULATION	39	10	0.0000463102771512268498967
CCC-004.6	237	2_COAGULATION	39	10	0.0000463102771512268498967
CCC-024.5	296	0_HALLMARK_COMPLEMENT	176	22	0.0000463447654127307708980
CCC-031.5	111	2_PEPTIDASE_ACTIVITY	129	12	0.0000531067059287914180511
CCC-025.3	260	2_WOUND_HEALING	46	11	0.0000533089009317242552496
CCC-030.1	192	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	10	0.0000537177764521484880423
CCC-003.4	381	2_EXTRACELLULAR_REGION_PART	269	32	0.0000562792206158284089653
CCC-001.3	181	2_LIPID_METABOLIC_PROCESS	174	17	0.0000564638639169402352619
CCC-014.4	251	2_LIPID_TRANSPORT	21	8	0.0000566142967830341465175
CCC-024.5	296	0_HALLMARK_MYC_TARGETS_V1	178	22	0.0000570571276002349633133
CCC-020.1	118	2_EXTRACELLULAR_REGION_PART	269	17	0.0000573308296317801262959
CCC-052.2	14	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	5	0.0000576592876775182253731
CCC-047.8	330	2_LIPID_METABOLIC_PROCESS	174	23	0.0000582993323674155166183
CCC-009.8	167	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0000588627734495136641546
CCC-011.2	194	2_ENDOPEPTIDASE_ACTIVITY	91	13	0.0000614904930932645254604
CCC-019.10	149	2_RESPONSE_TO_WOUNDING	163	15	0.0000627123125048121264364
CCC-026.4	163	2_LIPID_HOMEOSTASIS	13	6	0.0000631167678610141221407
CCC-026a.2	94	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	17	0.0000647105562776213602766
CCC-022.1	71	2_NUCLEAR_PART	466	17	0.0000669456334223121911266
CCC-024.5	296	2_ACTIN_CYTOSKELETON	109	17	0.0000697124502105001323232
CCC-009.8	167	2_CHEMICAL_HOMEOSTASIS	126	14	0.0000705307249059807731938
CCC-047.8	330	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	16	0.0000718548030365496987826
CCC-011.2	194	2_RESPONSE_TO_STRESS	427	28	0.0000722460647368513496054
CCC-009.8	167	2_LIPID_HOMEOSTASIS	13	6	0.0000729757794852933810601
CCC-022.1	71	2_CHROMOSOME_ORGANIZATION_AND_BIOGENESIS	99	9	0.0000775265150569563705552
CCC-026.4	163	2_HEMOSTASIS	44	9	0.0000775388313768187223927
CCC-014.4	251	2_BLOOD_COAGULATION	39	10	0.0000798646090791628850483
CCC-014.4	251	2_COAGULATION	39	10	0.0000798646090791628850483
CCC-003.4	381	2_EXTRACELLULAR_REGION	346	37	0.0000798822041908821305805
CCC-024.5	296	2_RESPONSE_TO_STRESS	427	36	0.0000820268477822560084043
CCC-018.6	223	2_RESPONSE_TO_WOUNDING	163	18	0.0000828552074633893417084
CCC-003.4	381	2_LIPID_TRANSPORT	21	9	0.0000829459779815365196498
CCC-024.5	296	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	27	0.0000838338371544711740508
CCC-003.4	381	2_EXTRACELLULAR_SPACE	192	26	0.0000842660635997763201796
CCC-016.8	265	2_LIPID_TRANSPORT	21	8	0.0000864004203648880396166
CCC-011.2	194	2_PEPTIDASE_ACTIVITY	129	15	0.0000919342017434870734539
CCC-026a.1	7	2_SARCOMERE	12	3	0.0000923432016349153141988
CCC-014.4	251	2_RESPONSE_TO_WOUNDING	163	19	0.0000964929845704359464859
CCC-010.3	154	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	9	0.0001058536506180709520350
CCC-025.3	260	2_EXTRACELLULAR_SPACE	192	21	0.0001075387703405997940264
CCC-009.8	167	2_LIPID_METABOLIC_PROCESS	174	16	0.0001104993827234081280476
CCC-025.3	260	2_BLOOD_COAGULATION	39	10	0.0001114254724924186693317
CCC-025.3	260	2_COAGULATION	39	10	0.0001114254724924186693317
CCC-001.3	181	2_LIPID_HOMEOSTASIS	13	6	0.0001180638627353156262009
CCC-025.3	260	0_HALLMARK_COMPLEMENT	176	20	0.0001183136603612919247278
CCC-016.8	265	1_KEGG_GLYCOLYSIS_GLUCONEOGENESIS	49	11	0.0001314785363989394841120
CCC-004.6	237	0_HALLMARK_COMPLEMENT	176	19	0.0001336537011667056319090
CCC-019.10	149	2_LIPID_METABOLIC_PROCESS	174	15	0.0001503529784816330389791
CCC-018.6	223	0_HALLMARK_XENOBIOTIC_METABOLISM	134	16	0.0001580903271564391456006
CCC-004.6	237	2_HEMOSTASIS	44	10	0.0001618860468975436570430
CCC-031.5	111	2_ENDOPEPTIDASE_ACTIVITY	91	10	0.0001630837843006755492111
CCC-030.1	192	2_LIPID_HOMEOSTASIS	13	6	0.0001678324018570048141007
CCC-024.5	296	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	31	0.0001702836034787698002435
CCC-023.2	39	2_REGULATION_OF_TRANSLATIONAL_INITIATION	29	5	0.0001715524378226803998287
CCC-003.4	381	2_HEMOSTASIS	44	12	0.0001722640648076314456080
CCC-026.4	163	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	9	0.0001729167441959335923141
CCC-016.8	265	2_RESPONSE_TO_STRESS	427	33	0.0001729529249124172783029
CCC-003.4	381	2_ENDOPEPTIDASE_ACTIVITY	91	17	0.0001738047468132951833483
CCC-052.5	91	1_KEGG_PYRUVATE_METABOLISM	25	6	0.0001746032774650147043494
CCC-019.10	149	0_HALLMARK_COMPLEMENT	176	15	0.0001749841202080839827095
CCC-052.5	91	0_HALLMARK_COMPLEMENT	176	12	0.0001781070312363102988752
CCC-011.2	194	2_LIPID_HOMEOSTASIS	13	6	0.0001785151153491099508368
CCC-018.6	223	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0001838376195706740978946
CCC-035.3	13	1_KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	35	4	0.0001862272276186928193688
CCC-013.8	242	0_HALLMARK_COMPLEMENT	176	19	0.0001862324465951225519866
CCC-019.9	21	2_CYTOSKELETON	293	8	0.0001882497432908520782965
CCC-020.1	118	2_MONOOXYGENASE_ACTIVITY	20	6	0.0001896893044145947612895
CCC-037.1	4	1_KEGG_REGULATION_OF_AUTOPHAGY	30	3	0.0001948992264520510995281
CCC-020.1	118	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	8	0.0001959804372368834763339
CCC-024.5	296	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	21	0.0001977364179145817710357
CCC-026.4	163	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	19	0.0002026926799937022187666
CCC-026a.2	94	2_LIPID_METABOLIC_PROCESS	174	12	0.0002265485566084927764562
CCC-001.3	181	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	20	0.0002283338753498437409453
CCC-010.3	154	2_GLYCOSAMINOGLYCAN_BINDING	26	7	0.0002286007460159221330379
CCC-026a.2	94	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0002294497871732269970828
CCC-026.4	163	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0002501723276569014511005
CCC-001.3	181	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	23	0.0002618868732400819352921
CCC-025.3	260	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0002739307342032559463088
CCC-014.4	251	2_HEMOSTASIS	44	10	0.0002772815723267656141601
CCC-010.3	154	1_KEGG_RETINOL_METABOLISM	39	8	0.0002813533017113677234949
CCC-013.8	242	2_PEPTIDASE_ACTIVITY	129	16	0.0002860177683453700848808
CCC-009.8	167	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0002953836941540624377520
CCC-043.2	332	2_BIOPOLYMER_METABOLIC_PROCESS	1367	83	0.0003057172801229005704680
CCC-010.3	154	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	6	0.0003068112915507503258607
CCC-016.8	265	0_HALLMARK_XENOBIOTIC_METABOLISM	134	17	0.0003102617748854631304911
CCC-052.5	91	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	11	0.0003220295822622675787315
CCC-001.3	181	2_LIPID_BINDING	61	10	0.0003397215055286048395952
CCC-026.4	163	2_REGULATION_OF_BODY_FLUID_LEVELS	52	9	0.0003575881479613306256418
CCC-001.3	181	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0003678409749819918175308
CCC-014.4	251	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	55	0.0003753671389827498280564
CCC-025.3	260	2_HEMOSTASIS	44	10	0.0003851625356198037008690
CCC-010.3	154	2_POLYSACCHARIDE_BINDING	28	7	0.0004003738644356764518270
CCC-023.1	131	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	19	0.0004042529770701778222067
CCC-051.6	160	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	151	14	0.0004062411931174226089637
CCC-003.4	381	1_KEGG_RETINOL_METABOLISM	39	11	0.0004063036210432804441230
CCC-016.8	265	2_CYTOPLASM	1461	73	0.0004068696100593901816139
CCC-052.2	14	1_KEGG_RETINOL_METABOLISM	39	4	0.0004070955131103288614919
CCC-018.6	223	2_LIPID_HOMEOSTASIS	13	6	0.0004083226738700019794494
CCC-013.8	242	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	23	0.0004158933691452273767250
CCC-001.3	181	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	9	0.0004243553946932522146634
CCC-018.6	223	2_REGULATION_OF_APOPTOSIS	309	24	0.0004412069363569418294774
CCC-047.8	330	2_PROTEASE_INHIBITOR_ACTIVITY	28	9	0.0004504475816302866636801
CCC-020.1	118	2_RESPONSE_TO_STRESS	427	20	0.0004638788640008214420041
CCC-018.6	223	2_REGULATION_OF_PROGRAMMED_CELL_DEATH	310	24	0.0004683728318820117833728
CCC-023.2	39	2_CELLULAR_BIOSYNTHETIC_PROCESS	229	9	0.0004691776304768891046187
CCC-047.8	330	2_LIPID_TRANSPORT	21	8	0.0004704014074754813193834
CCC-026a.2	94	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	14	0.0004777933542080644202694
CCC-003.4	381	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	12	0.0004915727163492424186750
CCC-001.3	181	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0005119036735330367111560
CCC-019.10	149	2_HOMEOSTATIC_PROCESS	166	14	0.0005429348384473411948115
CCC-016.8	265	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	24	0.0005538810263412609780770
CCC-023.1	131	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	12	0.0005588070870017794022216
CCC-019.9	21	2_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0005601165838039231072501
CCC-019.9	21	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	9	0.0005601165838039231072501
CCC-020.1	118	2_LIPID_HOMEOSTASIS	13	5	0.0005604770913996250450428
CCC-026.4	163	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	5	0.0005709813461061227389190
CCC-031.5	111	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0005728747016701120050100
CCC-020.1	118	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0005750301878625008666565
CCC-004.6	237	2_LIPID_HOMEOSTASIS	13	6	0.0005854416944030966770199
CCC-023.2	39	2_TRANSLATIONAL_INITIATION	37	5	0.0006147343323433762619576
CCC-043.2	332	1_KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	66	13	0.0006331488804025034401388
CCC-010.3	154	2_RESPONSE_TO_STRESS	427	23	0.0006388646106311015107626
CCC-013.8	242	2_LIPID_HOMEOSTASIS	13	6	0.0006623023690806007467147
CCC-033.5	38	2_BLOOD_COAGULATION	39	5	0.0007057517040901969658864
CCC-033.5	38	2_COAGULATION	39	5	0.0007057517040901969658864
CCC-031.5	111	2_RESPONSE_TO_WOUNDING	163	12	0.0007062203479467643076062
CCC-025.3	260	2_PEPTIDASE_ACTIVITY	129	16	0.0007598095539799342617096
CCC-030.1	192	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0007645926318549006771644
CCC-030.1	192	2_CELLULAR_COMPONENT_DISASSEMBLY	25	7	0.0007645926318549006771644
CCC-011.2	194	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	9	0.0007648254928410864192725
CCC-047.8	330	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	27	0.0007713861521907758138361
CCC-013.8	242	2_LIPID_METABOLIC_PROCESS	174	18	0.0007741171359677429799837
CCC-003.4	381	2_LIPID_METABOLIC_PROCESS	174	23	0.0007891041717753930623269
CCC-013.8	242	2_ENDOPEPTIDASE_ACTIVITY	91	13	0.0008139034765641714160370
CCC-011.2	194	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0008202877938454333469134
CCC-020.1	118	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0008236282640813797793419
CCC-026a.2	94	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0008333304236087655430046
CCC-025.3	260	2_RESPONSE_TO_WOUNDING	163	18	0.0008402425718581975648200
CCC-055.4	7	1_KEGG_RNA_POLYMERASE	24	3	0.0008463220097907590703037
CCC-023.2	39	0_HALLMARK_MYC_TARGETS_V1	178	8	0.0008564107131371668808067
CCC-004.6	237	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0008654296180732864779070
CCC-003.4	381	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	23	0.0008753536419037343148386
CCC-043.2	332	2_TRANSCRIPTION	667	49	0.0008989775750998891742927
CCC-026.4	163	2_OXYGEN_BINDING	19	6	0.0009157560105049688484874
CCC-010.3	154	2_HEPARIN_BINDING	20	6	0.0009227692022863759509221
CCC-018.6	223	0_HALLMARK_ANGIOGENESIS	32	8	0.0009266829423234673734910
CCC-026a.1	7	2_CYTOSKELETON	293	5	0.0009353020786578065568981
CCC-030.1	192	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	14	0.0009542196612778763896781
CCC-025.3	260	2_PROTEASE_INHIBITOR_ACTIVITY	28	8	0.0009623992410961187222648
CCC-003.4	381	0_HALLMARK_COMPLEMENT	176	23	0.0009701963926150671858883
CCC-024.5	296	1_KEGG_LINOLEIC_ACID_METABOLISM	25	8	0.0009702005369041811089909
CCC-001.3	181	1_KEGG_RETINOL_METABOLISM	39	8	0.0009729031695691282757149
CCC-009.8	167	2_OXYGEN_BINDING	19	6	0.0010564735172356725257520
CCC-025.3	260	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	13	0.0010827802664871650009659
CCC-016.8	265	2_LIPID_HOMEOSTASIS	13	6	0.0011311866583529482828407
CCC-018.6	223	2_NEGATIVE_REGULATION_OF_APOPTOSIS	136	15	0.0011444629036907207324941
CCC-052.2	14	0_HALLMARK_COAGULATION	125	5	0.0011505795753042067156025
CCC-018.6	223	2_LIPID_METABOLIC_PROCESS	174	17	0.0011646117028229490027169
CCC-019.10	149	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	8	0.0011853386364537735545022
CCC-024.5	296	2_SARCOMERE	12	6	0.0011977833438265384283228
CCC-033.5	38	2_EXTRACELLULAR_REGION	346	10	0.0012187886632674070890719
CCC-001.3	181	2_APOPTOTIC_PROGRAM	54	9	0.0012189113268124811967352
CCC-043.2	332	2_LIPID_METABOLIC_PROCESS	174	21	0.0012192812310592440142726
CCC-033.5	38	2_EXTRACELLULAR_SPACE	192	8	0.0012324110591898204594002
CCC-047.8	330	2_RESPONSE_TO_STRESS	427	36	0.0012522507142827227037685
CCC-003.4	381	2_REGULATION_OF_BODY_FLUID_LEVELS	52	12	0.0012580802555297238617266
CCC-018.6	223	2_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH	137	15	0.0012586005196668979648489
CCC-033.5	38	2_HEMOSTASIS	44	5	0.0013119320816333123348035
CCC-014.4	251	0_HALLMARK_G2M_CHECKPOINT	174	18	0.0013249232399730286307421
CCC-043.2	332	2_TRANSCRIPTION_COFACTOR_ACTIVITY	205	23	0.0013304985086991117509969
CCC-010.3	154	0_HALLMARK_KRAS_SIGNALING_UP	148	13	0.0013389347540020330763755
CCC-010.3	154	2_PATTERN_BINDING	33	7	0.0013490838340910508378473
CCC-022.1	71	2_CYTOPLASM	1461	28	0.0013810246019864789047277
CCC-019.10	149	1_KEGG_GLYCOLYSIS_GLUCONEOGENESIS	49	8	0.0013978773931083501858019
CCC-019.9	21	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	83	5	0.0014266825162619735725689
CCC-033.5	38	2_EXTRACELLULAR_REGION_PART	269	9	0.0014365835094776089296553
CCC-047.8	330	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	7	0.0014466819972588642554540
CCC-014.4	251	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0014662576184357150720777
CCC-019.10	149	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0014698732145737736926039
CCC-009.8	167	2_MONOOXYGENASE_ACTIVITY	20	6	0.0014872532071922954510779
CCC-003.4	381	2_PEPTIDASE_ACTIVITY	129	19	0.0015146880250207117764305
CCC-010.3	154	2_CHEMICAL_HOMEOSTASIS	126	12	0.0015228470091909469645575
CCC-010.3	154	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	8	0.0015240917645601848983555
CCC-023.1	131	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0015272215678417996702343
CCC-025.3	260	2_LIPID_TRANSPORT	21	7	0.0015575098548615748644125
CCC-047.8	330	0_HALLMARK_ANGIOGENESIS	32	9	0.0016163825045805242566072
CCC-047.8	330	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	18	0.0016359567904887055683066
CCC-010.3	154	1_KEGG_ECM_RECEPTOR_INTERACTION	84	10	0.0016398329911378394744409
CCC-033.5	38	2_WOUND_HEALING	46	5	0.0016462813444372680765637
CCC-018.6	223	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	21	0.0016478266875516991898237
CCC-011.2	194	1_KEGG_RETINOL_METABOLISM	39	8	0.0016481920367724738844123
CCC-003.6	7	2_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_NOT_PEPTIDEBONDS	30	3	0.0016944241282201421162218
CCC-024.5	296	2_OXYGEN_BINDING	19	7	0.0017005369660929277667027
CCC-020.1	118	1_KEGG_PPAR_SIGNALING_PATHWAY	63	8	0.0017211270859752087532962
CCC-013.8	242	0_HALLMARK_ANGIOGENESIS	32	8	0.0017236352141110564129001
CCC-047.8	330	2_SKELETAL_DEVELOPMENT	84	14	0.0017908808152139184081963
CCC-009.8	167	2_LIPID_BINDING	61	9	0.0018094281716931523949776
CCC-022.1	71	2_NUCLEOPLASM	233	11	0.0019050672509929090538139
CCC-055.3	41	1_KEGG_NOTCH_SIGNALING_PATHWAY	44	5	0.0019385631019902976358849
CCC-025.3	260	2_REGULATION_OF_BODY_FLUID_LEVELS	52	10	0.0020225068060223247087825
CCC-026.4	163	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0021074980335091557034910
CCC-010.3	154	2_PROTEOLYSIS	154	13	0.0021089946738286242944316
CCC-010.3	154	2_LIPID_HOMEOSTASIS	13	5	0.0021106165971143892381989
CCC-019.9	21	1_KEGG_DILATED_CARDIOMYOPATHY	90	5	0.0021382245664079663031998
CCC-022.1	71	2_MACROMOLECULAR_COMPLEX	812	20	0.0021403057979501446603243
CCC-024.5	296	2_LIPID_HOMEOSTASIS	13	6	0.0021660616884247971443422
CCC-009.8	167	2_HOMEOSTATIC_PROCESS	166	14	0.0021863072516973914086180
CCC-025.3	260	2_LIPID_METABOLIC_PROCESS	174	18	0.0022119025005628428770521
CCC-014.4	251	1_KEGG_DNA_REPLICATION	32	8	0.0022707485950833731537524
CCC-016.8	265	2_ENDOPEPTIDASE_ACTIVITY	91	13	0.0022790899874751799521200
CCC-043.2	332	2_TRANSCRIPTION_DNA_DEPENDENT	569	43	0.0023117318023938601516398
CCC-009.8	167	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0023225914943136851883998
CCC-026.4	163	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	8	0.0023442225572188161997200
CCC-014.4	251	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	26	0.0023538444471167610516638
CCC-001.3	181	2_MONOOXYGENASE_ACTIVITY	20	6	0.0023846369793554585830853
CCC-030.1	192	2_OXYGEN_BINDING	19	6	0.0023965221075680559134624
CCC-023.2	39	2_REGULATION_OF_CELLULAR_PROTEIN_METABOLIC_PROCESS	141	7	0.0024769333839628820612133
CCC-018.6	223	2_CHEMICAL_HOMEOSTASIS	126	14	0.0024885883462434968925459
CCC-018.6	223	2_APOPTOSIS_GO	389	26	0.0024938533645433602105312
CCC-037.4	2	2_SARCOMERE	12	2	0.0024993486097923873524851
CCC-043.2	332	2_RNA_BIOSYNTHETIC_PROCESS	571	43	0.0025373381304317579355845
CCC-011.2	194	2_OXYGEN_BINDING	19	6	0.0025462576625610760031049
CCC-014.4	251	2_DNA_REPLICATION	82	12	0.0025551751248472252472932
CCC-024.5	296	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	8	0.0025683583149323950187148
CCC-020.1	118	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0025891226166743102655998
CCC-023.1	131	2_RESPONSE_TO_STRESS	427	20	0.0026020612279991309906402
CCC-018.6	223	2_PROGRAMMED_CELL_DEATH	390	26	0.0026169320113405575983778
CCC-020.1	118	2_STEROL_BINDING	8	4	0.0026319371856342106859306
CCC-025.3	260	2_ACTIN_CYTOSKELETON	109	14	0.0026416581909533003343082
CCC-035.2	59	2_ENDOPLASMIC_RETICULUM_PART	59	6	0.0026941406524076932232914
CCC-043.2	332	0_HALLMARK_COAGULATION	125	17	0.0026987682886175819174657
CCC-018.6	223	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	6	0.0027202118001329496366214
CCC-009.8	167	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	8	0.0028149517451978157793480
CCC-014.4	251	2_PATTERN_BINDING	33	8	0.0029291531091297602282242
CCC-023.1	131	2_LIPID_BINDING	61	8	0.0029599987620112541523987
CCC-026.4	163	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	20	0.0030068804109218052328378
CCC-024.5	296	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	10	0.0030106504802540610434003
CCC-009.8	167	2_ENZYME_REGULATOR_ACTIVITY	277	18	0.0030226238434473400723546
CCC-033.5	38	2_REGULATION_OF_BODY_FLUID_LEVELS	52	5	0.0030672037209129024079579
CCC-026a.2	94	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0031155288884254510491101
CCC-001.3	181	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0032062696825839536417246
CCC-022.1	71	2_INTRACELLULAR_ORGANELLE_PART	912	21	0.0032120138850435155791763
CCC-026.4	163	2_MICROSOME	23	6	0.0032176042404186773644714
CCC-019.10	149	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0032506216877255041282357
CCC-024.5	296	2_LIPID_METABOLIC_PROCESS	174	19	0.0034449249657408317383533
CCC-022.1	71	2_ORGANELLE_PART	916	21	0.0034480308336087661484626
CCC-023.2	39	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	5	0.0035036851269623554318289
CCC-009.8	167	1_KEGG_PRION_DISEASES	35	7	0.0035605345182745540971725
CCC-011.2	194	2_MONOOXYGENASE_ACTIVITY	20	6	0.0035756548271389577454971
CCC-013.8	242	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0036331200693099732247637
CCC-022.1	71	2_NUCLEAR_LUMEN	302	12	0.0036526782601318530385726
CCC-047.8	330	2_PEPTIDASE_ACTIVITY	129	17	0.0038769386219945846557000
CCC-013.8	242	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	17	0.0039288293697314511862539
CCC-010.3	154	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0039413865100157274151682
CCC-003.4	381	1_KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	48	11	0.0039480525583626413510530
CCC-031.5	111	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	16	0.0039792978702378840535903
CCC-023.1	131	2_STEROL_BINDING	8	4	0.0040006969709221124401055
CCC-016.8	265	0_HALLMARK_MYC_TARGETS_V1	178	18	0.0040472967941995452445525
CCC-030.1	192	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0040597975633964019856470
CCC-024.5	296	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	13	0.0040640268222171581705138
CCC-047.8	330	2_LIPID_HOMEOSTASIS	13	6	0.0040895907410193350212113
CCC-023.2	39	2_REGULATION_OF_PROTEIN_METABOLIC_PROCESS	152	7	0.0041004585356004775650862
CCC-052.2	14	2_OXYGEN_BINDING	19	3	0.0041831937185083456834378
CCC-014.4	251	0_HALLMARK_XENOBIOTIC_METABOLISM	134	15	0.0041983021738556227167583
CCC-026.4	163	2_VESICULAR_FRACTION	24	6	0.0042292189975417565292459
CCC-011.2	194	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0042315410502875650325394
CCC-023.2	39	2_PROTEIN_RNA_COMPLEX_ASSEMBLY	54	5	0.0042378631959084341399024
CCC-014.4	251	2_NEGATIVE_REGULATION_OF_BIOLOGICAL_PROCESS	569	35	0.0042627910786309300417152
CCC-004.6	237	2_ENDOPEPTIDASE_ACTIVITY	91	12	0.0043421420841810729265853
CCC-050.3	4	1_KEGG_ECM_RECEPTOR_INTERACTION	84	3	0.0045544274918195449403102
CCC-014.4	251	2_CELLULAR_COMPONENT_DISASSEMBLY	25	7	0.0046348206248528816750265
CCC-009.8	167	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0047615795611533739267740
CCC-020.1	118	2_OXYGEN_BINDING	19	5	0.0047689657194493256450740
CCC-043.2	332	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS	1027	64	0.0048059555897099013460627
CCC-047.8	330	2_ENDOPEPTIDASE_ACTIVITY	91	14	0.0048314631215435914143863
CCC-014.4	251	2_ACUTE_INFLAMMATORY_RESPONSE	10	5	0.0048573769408247272072465
CCC-018.6	223	2_PROTEASE_INHIBITOR_ACTIVITY	28	7	0.0048717755117087735081127
CCC-023.2	39	2_BIOSYNTHETIC_PROCESS	303	9	0.0048890821965611019200848
CCC-052.5	91	0_HALLMARK_COAGULATION	125	9	0.0049447014664459462349178
CCC-052.5	91	1_KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	66	7	0.0050515523435297879015216
CCC-011.2	194	0_HALLMARK_ANGIOGENESIS	32	7	0.0050846164099028062777208
CCC-037.4	2	2_MYOFIBRIL	17	2	0.0051501728929119654568081
CCC-019.9	21	2_ACTIN_CYTOSKELETON	109	5	0.0055326831899813588150350
CCC-010.3	154	2_ENZYME_INHIBITOR_ACTIVITY	96	10	0.0056679814221021317804938
CCC-025.3	260	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0058583465288463976161637
CCC-035.3	13	0_HALLMARK_PROTEIN_SECRETION	82	4	0.0060011319603726015828316
CCC-020.1	118	2_CHEMICAL_HOMEOSTASIS	126	10	0.0060673038819229240317665
CCC-001.3	181	1_KEGG_PRION_DISEASES	35	7	0.0060904525830700441749177
CCC-019.10	149	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	16	0.0061861962874529561121073
CCC-014.4	251	2_GLYCOSAMINOGLYCAN_BINDING	26	7	0.0061997009141932998832480
CCC-047.8	330	0_HALLMARK_KRAS_SIGNALING_UP	148	18	0.0063110268627106997155196
CCC-011.2	194	2_PATTERN_BINDING	33	7	0.0063422566580067923913688
CCC-018.6	223	2_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS	176	16	0.0064817920167404034434422
CCC-003.4	381	1_KEGG_LINOLEIC_ACID_METABOLISM	25	8	0.0064955586490364897178651
CCC-023.1	131	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	7	0.0065042963465593772384721
CCC-037.2	8	0_HALLMARK_IL2_STAT5_SIGNALING	148	4	0.0065146925495883365245242
CCC-024.5	296	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	10	0.0065166801397500851572575
CCC-013.8	242	2_CHEMICAL_HOMEOSTASIS	126	14	0.0065286933249748303753623
CCC-004.6	237	2_PEPTIDASE_ACTIVITY	129	14	0.0067708529255622856152241
CCC-043.2	332	0_HALLMARK_XENOBIOTIC_METABOLISM	134	17	0.0071491185800842899436547
CCC-037.4	2	2_CONTRACTILE_FIBER_PART	20	2	0.0071950944827481704002548
CCC-023.1	131	0_HALLMARK_ANGIOGENESIS	32	6	0.0072165072338677650407024
CCC-004.6	237	2_PROTEASE_INHIBITOR_ACTIVITY	28	7	0.0072986895464363021543419
CCC-018.6	223	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0073808751990669420328661
CCC-009.8	167	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	12	0.0074595195194677929584337
CCC-018.6	223	0_HALLMARK_MYC_TARGETS_V1	178	16	0.0075091220709249898584980
CCC-009.8	167	1_KEGG_RETINOL_METABOLISM	39	7	0.0076736725898210759663765
CCC-043.2	332	2_TRANSCRIPTION_FACTOR_BINDING	277	26	0.0076876437298935215713946
CCC-014.4	251	2_ENDOPEPTIDASE_ACTIVITY	91	12	0.0078724260811891214745240
CCC-022.1	71	2_DNA_METABOLIC_PROCESS	218	10	0.0079389345553403274646787
CCC-014.4	251	2_REPLICATION_FORK	18	6	0.0079458548211756470369682
CCC-023.1	131	2_OXYGEN_BINDING	19	5	0.0079815725031025432784082
CCC-019.10	149	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0081872014125416135710278
CCC-052.5	91	1_KEGG_INSULIN_SIGNALING_PATHWAY	133	9	0.0082638945201130385026511
CCC-011.2	194	1_KEGG_PPAR_SIGNALING_PATHWAY	63	9	0.0082746809000800274069842
CCC-030.1	192	2_MICROSOME	23	6	0.0083316101236530180906836
CCC-001.3	181	2_CHEMICAL_HOMEOSTASIS	126	12	0.0083506555196122683737414
CCC-013.8	242	1_KEGG_RETINOL_METABOLISM	39	8	0.0086334164395051472135068
CCC-024.5	296	2_IDENTICAL_PROTEIN_BINDING	256	23	0.0086636909760513698686157
CCC-013.8	242	2_HOMEOSTATIC_PROCESS	166	16	0.0086895650552864488191940
CCC-037.4	2	2_CONTRACTILE_FIBER	22	2	0.0087477201342904507830323
CCC-022.1	71	2_ESTABLISHMENT_AND_OR_MAINTENANCE_OF_CHROMATIN_ARCHITECTURE	60	6	0.0089274745905966301079415
CCC-030.1	192	1_KEGG_PRION_DISEASES	35	7	0.0090040442194676308107493
CCC-003.4	381	2_OXYGEN_BINDING	19	7	0.0091802147595048486788949
CCC-047.8	330	2_ENZYME_INHIBITOR_ACTIVITY	96	14	0.0092423157701857928253419
CCC-004.6	237	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0094087031019624515343347
CCC-003.4	381	2_LIPID_HOMEOSTASIS	13	6	0.0094262418761890016949412
CCC-052.2	14	2_EXTRACELLULAR_SPACE	192	5	0.0095913853997695360659170
CCC-011.2	194	1_KEGG_PRION_DISEASES	35	7	0.0096419282651155346908212
CCC-009.8	167	2_RESPONSE_TO_STRESS	427	22	0.0097444731943485095315705
CCC-001.3	181	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	10	0.0098016547430523019018844
CCC-001.3	181	2_CELLULAR_COMPONENT_DISASSEMBLY	25	6	0.0100606220945038786485082
CCC-013.8	242	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0102247377120905213326862
CCC-026a.1	7	2_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277796640258
CCC-026a.1	7	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	5	0.0103727800439277796640258
CCC-052.5	91	2_LIPID_METABOLIC_PROCESS	174	10	0.0103883904319210275402074
CCC-025.3	260	2_CYTOSKELETAL_PART	194	18	0.0105465989534153960216489
CCC-001.3	181	2_CELL_STRUCTURE_DISASSEMBLY_DURING_APOPTOSIS	15	5	0.0106054507265315629827018
CCC-019.9	21	2_BASAL_LAMINA	17	3	0.0106615582506913823823691
CCC-014.4	251	2_PROTEASE_INHIBITOR_ACTIVITY	28	7	0.0106632241703235614710410
CCC-014.4	251	2_POLYSACCHARIDE_BINDING	28	7	0.0106632241703235614710410
CCC-030.1	192	2_VESICULAR_FRACTION	24	6	0.0109221206163447898812580
CCC-014.4	251	2_RESPONSE_TO_EXTERNAL_STIMULUS	263	21	0.0109706060092120347149169
CCC-016.8	265	2_LIPID_BINDING	61	10	0.0109753619067389819596858
CCC-014.4	251	2_NEGATIVE_REGULATION_OF_CELLULAR_PROCESS	543	33	0.0110169201486081634600023
CCC-001.3	181	2_RESPONSE_TO_STRESS	427	23	0.0110681361214666155318165
CCC-030.1	192	2_HOMEOSTATIC_PROCESS	166	14	0.0113591573965191958844878
CCC-052.5	91	1_KEGG_MTOR_SIGNALING_PATHWAY	49	6	0.0114525859418177309440035
CCC-022.1	71	2_ORGANELLE_LUMEN	338	12	0.0116878859990558591624987
CCC-022.1	71	2_MEMBRANE_ENCLOSED_LUMEN	338	12	0.0116878859990558591624987
CCC-023.1	131	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0117456616256188580565967
CCC-014.4	251	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0118249650334492986680779
CCC-030.1	192	2_SKELETAL_DEVELOPMENT	84	10	0.0120239857984023850584476
CCC-010.3	154	2_CARBOHYDRATE_BINDING	45	7	0.0121640807046292619142402
CCC-004.6	237	2_LIPID_METABOLIC_PROCESS	174	16	0.0122208470317244320690886
CCC-001.3	181	2_CELL_FRACTION	339	20	0.0122354079278995594992629
CCC-023.2	39	2_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS_AND_ASSEMBLY	67	5	0.0124456731721767823589664
CCC-033.5	38	0_HALLMARK_ANGIOGENESIS	32	4	0.0124715543219240335842679
CCC-023.1	131	1_KEGG_PRION_DISEASES	35	6	0.0124928539024533376972093
CCC-011.2	194	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	21	0.0125440535537208429361922
CCC-026.4	163	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0127114294404397851212529
CCC-010.3	154	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	83	9	0.0127639333287116775450531
CCC-051.1	12	2_UNFOLDED_PROTEIN_BINDING	32	3	0.0128544008380830319937527
CCC-013.8	242	2_MONOOXYGENASE_ACTIVITY	20	6	0.0128627316674417672970332
CCC-023.2	39	2_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX	10	3	0.0129281385191089750325011
CCC-004.6	237	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0131538728610686699721510
CCC-020.1	118	2_MICROSOME	23	5	0.0132597680620913233040525
CCC-047.8	330	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	13	0.0133877367339263718404307
CCC-025.3	260	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0136045765222164993790699
CCC-024.5	296	2_CELLULAR_COMPONENT_DISASSEMBLY	25	7	0.0137962052649238439000490
CCC-023.2	39	2_UNFOLDED_PROTEIN_BINDING	32	4	0.0138639268089902224084797
CCC-024.5	296	2_MYOFIBRIL	17	6	0.0140469055516853798259991
CCC-024.5	296	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	6	0.0140469055516853798259991
CCC-018.6	223	2_HOMEOSTATIC_PROCESS	166	15	0.0141187864967167609614451
CCC-030.1	192	2_CELL_STRUCTURE_DISASSEMBLY_DURING_APOPTOSIS	15	5	0.0141505017154429837272778
CCC-004.6	237	2_RESPONSE_TO_STRESS	427	27	0.0142342637644484425185620
CCC-043.2	332	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	13	0.0142916417868725088846649
CCC-009.8	167	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0143096979432347434779693
CCC-037.4	2	2_STRUCTURAL_CONSTITUENT_OF_MUSCLE	28	2	0.0143144511288428172290921
CCC-014.4	251	0_HALLMARK_KRAS_SIGNALING_UP	148	15	0.0144867915133487321771577
CCC-001.3	181	2_STEROL_BINDING	8	4	0.0145178736603644286534687
CCC-016.8	265	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0146754065904298666711547
CCC-013.8	242	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	14	0.0147184063831578212933060
CCC-030.1	192	2_DNA_METABOLIC_PROCESS	218	16	0.0148822029176942892403357
CCC-023.1	131	2_PROTEOLYSIS	154	11	0.0150843378347025637575829
CCC-031.5	111	2_RESPONSE_TO_STRESS	427	17	0.0152082100715311193533941
CCC-030.1	192	2_CHEMICAL_HOMEOSTASIS	126	12	0.0153070771050832412502052
CCC-010.3	154	2_EXTRACELLULAR_MATRIX	85	9	0.0155513859267301986916143
CCC-018.6	223	2_CELL_DEVELOPMENT	511	29	0.0156880571626941862917182
CCC-024.5	296	1_KEGG_PRION_DISEASES	35	8	0.0160635144243826029353261
CCC-016.8	265	2_NON_MEMBRANE_BOUND_ORGANELLE	476	31	0.0163208146807695235469549
CCC-016.8	265	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	476	31	0.0163208146807695235469549
CCC-016.6	2	0_HALLMARK_NOTCH_SIGNALING	30	2	0.0164729794736685093703432
CCC-055.3	41	0_HALLMARK_MYC_TARGETS_V1	178	7	0.0165634833392322641798522
CCC-020.1	118	2_VESICULAR_FRACTION	24	5	0.0165827669011955405875547
CCC-014.4	251	2_BIOPOLYMER_METABOLIC_PROCESS	1367	62	0.0166948049320822695940070
CCC-020.1	118	2_LIPID_BINDING	61	7	0.0167356042680946830170097
CCC-014.4	251	0_HALLMARK_APOPTOSIS	150	15	0.0170702470692815876096571
CCC-001.3	181	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	12	0.0170757251790330140395202
CCC-055.4	7	1_KEGG_PYRIMIDINE_METABOLISM	64	3	0.0172009812684550539296779
CCC-043.2	332	1_KEGG_PPAR_SIGNALING_PATHWAY	63	11	0.0173081601653067573831635
CCC-014.4	251	2_DOUBLE_STRANDED_DNA_BINDING	30	7	0.0175192262158477309041960
CCC-037.2	8	0_HALLMARK_ALLOGRAFT_REJECTION	190	4	0.0176015604471078251913596
CCC-020.1	118	2_STEROID_BINDING	12	4	0.0179042127827753437541158
CCC-047.8	330	2_ORGAN_DEVELOPMENT	460	35	0.0182445348588114765464585
CCC-019.10	149	2_IMMUNE_EFFECTOR_PROCESS	33	6	0.0183196065802761764995665
CCC-052.3	2	2_UNFOLDED_PROTEIN_BINDING	32	2	0.0187829834918144984723387
CCC-011.2	194	2_STEROL_BINDING	8	4	0.0191175814626509607552229
CCC-011.2	194	2_GLYCOSAMINOGLYCAN_BINDING	26	6	0.0191640456399137654175391
CCC-013.8	242	2_PROTEIN_DIMERIZATION_ACTIVITY	157	15	0.0191816160389091348859036
CCC-004.6	237	2_REGULATION_OF_CELLULAR_PROTEIN_METABOLIC_PROCESS	141	14	0.0192066456402762014699093
CCC-025.3	260	2_CONTRACTILE_FIBER_PART	20	6	0.0194120263376819403300377
CCC-025.3	260	2_MONOOXYGENASE_ACTIVITY	20	6	0.0194120263376819403300377
CCC-018.6	223	2_LIPID_BINDING	61	9	0.0195099668048487467908458
CCC-001.3	181	2_MEMBRANE_FRACTION	210	15	0.0195515646063085454797736
CCC-019.10	149	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0195871318052476157955955
CCC-025.3	260	2_ENZYME_INHIBITOR_ACTIVITY	96	12	0.0198043098245261547929452
CCC-031.5	111	2_EXTRACELLULAR_REGION	346	15	0.0198333625820929018712668
CCC-013.8	242	2_PROTEIN_HETERODIMERIZATION_ACTIVITY	71	10	0.0199759019632341563998956
CCC-010.3	154	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	11	0.0201217082231537336411975
CCC-047.4	6	1_KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	9	2	0.0204088341522304095310147
CCC-047.4	6	2_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_NOT_PEPTIDEBONDSIN_CYCLIC_AMIDINES	9	2	0.0204088341522304095310147
CCC-020.1	118	2_OXIDOREDUCTASE_ACTIVITY	177	11	0.0208084416394267238126226
CCC-018.6	223	2_PROTEIN_METABOLIC_PROCESS	965	44	0.0209428282924420672284072
CCC-001.3	181	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0211826579489944842593641
CCC-014.4	251	2_NUCLEUS	1110	53	0.0212591105930795276623968
CCC-010.3	154	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0223239209508109201496318
CCC-024.5	296	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0227760621242765366745164
CCC-014.4	251	2_LIPID_HOMEOSTASIS	13	5	0.0232316148285526026529002
CCC-051.6	160	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	9	0.0233271904128094995090059
CCC-011.2	194	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	14	0.0235008988967923375390523
CCC-001.3	181	2_ENZYME_INHIBITOR_ACTIVITY	96	10	0.0238156302786197704435267
CCC-052.5	91	2_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY	33	5	0.0240552964980115420445816
CCC-022.1	71	2_CHROMATIN_MODIFICATION	42	5	0.0240694335283841431838425
CCC-016.8	265	2_PEPTIDASE_ACTIVITY	129	14	0.0244068265333395525984450
CCC-022.1	71	2_PROTEIN_COMPLEX	712	17	0.0247227965683873736335574
CCC-014.4	251	2_LIPID_METABOLIC_PROCESS	174	16	0.0252014749282652474049460
CCC-026.4	163	2_MEMBRANE_FRACTION	210	14	0.0256932616200782303061967
CCC-022.1	71	2_DNA_BINDING	496	14	0.0257568565462504873997407
CCC-019.10	149	1_KEGG_PRION_DISEASES	35	6	0.0261588123938262008538747
CCC-025.3	260	1_KEGG_ARACHIDONIC_ACID_METABOLISM	42	8	0.0261653574555870821471970
CCC-019.10	149	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	52	7	0.0262952439045348422552717
CCC-014.4	251	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	175	16	0.0270875717297131210492545
CCC-023.1	131	2_SARCOMERE	12	4	0.0270951137341128717173078
CCC-023.1	131	2_STEROID_BINDING	12	4	0.0270951137341128717173078
CCC-010.3	154	2_HOMEOSTATIC_PROCESS	166	12	0.0271890089647815920426144
CCC-043.2	332	0_HALLMARK_ADIPOGENESIS	133	16	0.0272048394344007321565826
CCC-018.6	223	2_REGULATION_OF_DEVELOPMENTAL_PROCESS	391	24	0.0275453152542853435535974
CCC-025.3	260	2_LIPID_HOMEOSTASIS	13	5	0.0275660202068715790013620
CCC-014.4	251	0_HALLMARK_ANGIOGENESIS	32	7	0.0276786867272497370817685
CCC-047.8	330	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0280786223815087318533834
CCC-043.2	332	2_RNA_METABOLIC_PROCESS	711	47	0.0281067754616553117097411
CCC-025.3	260	2_RESPONSE_TO_STRESS	427	28	0.0281513772513681398423913
CCC-030.1	192	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0282081213411796739853887
CCC-004.6	237	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	23	0.0285107042757545246780548
CCC-001.3	181	2_HOMEOSTATIC_PROCESS	166	13	0.0288428367628620584139920
CCC-018.6	223	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	13	0.0289222369803565776402721
CCC-016.8	265	2_ENVELOPE	131	14	0.0291299673111585534501788
CCC-016.8	265	2_ORGANELLE_ENVELOPE	131	14	0.0291299673111585534501788
CCC-043.2	332	1_KEGG_LINOLEIC_ACID_METABOLISM	25	7	0.0292032947035797338375396
CCC-011.2	194	2_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY	17	5	0.0296608007778271717813645
CCC-011.2	194	2_LIPID_TRANSPORTER_ACTIVITY	17	5	0.0296608007778271717813645
CCC-026.4	163	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	9	0.0297680746519623819212885
CCC-023.2	39	2_REGULATION_OF_TRANSLATION	80	5	0.0297929685276070201072063
CCC-052.5	91	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	86	7	0.0298215099403985745007972
CCC-011.2	194	2_PROTEASE_INHIBITOR_ACTIVITY	28	6	0.0303041797824709670250432
CCC-011.2	194	2_POLYSACCHARIDE_BINDING	28	6	0.0303041797824709670250432
CCC-026.4	163	2_MONOOXYGENASE_ACTIVITY	20	5	0.0305401029823035817523103
CCC-009.8	167	2_ACUTE_INFLAMMATORY_RESPONSE	10	4	0.0307602385117013883697457
CCC-009.8	167	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0307602385117013883697457
CCC-035.2	59	2_ENDOPLASMIC_RETICULUM_MEMBRANE	53	5	0.0308122346974011099285384
CCC-001.3	181	2_PROTEIN_HOMODIMERIZATION_ACTIVITY	99	10	0.0313025303663456155867095
CCC-024.5	296	2_PROTEASE_INHIBITOR_ACTIVITY	28	7	0.0313419926879999685698230
CCC-010.3	154	1_KEGG_PRION_DISEASES	35	6	0.0315737683030786614457597
CCC-031.5	111	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	6	0.0318714456490650152598043
CCC-019.10	149	2_ENZYME_INHIBITOR_ACTIVITY	96	9	0.0323075283345197750151101
CCC-052.5	91	2_SERINE_TYPE_PEPTIDASE_ACTIVITY	35	5	0.0324075749362326206992613
CCC-043.2	332	0_HALLMARK_APOPTOSIS	150	17	0.0328151311344174537176777
CCC-018.6	223	2_STEROL_BINDING	8	4	0.0331801652934119589710704
CCC-025.3	260	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	14	0.0331826887275266588228639
CCC-003.4	381	2_RESPONSE_TO_STRESS	427	36	0.0341249393838247774835004
CCC-011.2	194	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	12	0.0343894464282580719638460
CCC-026.4	163	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	11	0.0344037290942207640842554
CCC-014.4	251	2_CARBOHYDRATE_BINDING	45	8	0.0345105131884294938360291
CCC-011.2	194	2_CELL_FRACTION	339	20	0.0345139431003927688035304
CCC-004.6	237	2_ENZYME_REGULATOR_ACTIVITY	277	20	0.0345650437162509024946466
CCC-022.1	71	2_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION_AND_BIOGENESIS	113	7	0.0347325193968295795055035
CCC-025.3	260	0_HALLMARK_ANGIOGENESIS	32	7	0.0347801473956908316353953
CCC-047.8	330	2_TRIACYLGLYCEROL_METABOLIC_PROCESS	6	4	0.0350522045418355937540511
CCC-047.8	330	1_KEGG_PRION_DISEASES	35	8	0.0354509510993148493906979
CCC-026a.2	94	2_PROTEOLYSIS	154	9	0.0354660441575785009837851
CCC-025.3	260	2_CONTRACTILE_FIBER	22	6	0.0356748923178063087613410
CCC-016.6	2	1_KEGG_NOTCH_SIGNALING_PATHWAY	44	2	0.0358239967404215126078881
CCC-020.1	118	2_PROTEASE_INHIBITOR_ACTIVITY	28	5	0.0368430241087347176698330
CCC-052.5	91	2_SERINE_HYDROLASE_ACTIVITY	36	5	0.0373501280362667775758467
CCC-003.4	381	2_ACUTE_INFLAMMATORY_RESPONSE	10	5	0.0374185480703666251134365
CCC-026a.1	7	1_KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	83	3	0.0377037833165463839857345
CCC-003.4	381	2_DNA_METABOLIC_PROCESS	218	23	0.0377672890751528794739400
CCC-022.1	71	2_ORGANELLE_ORGANIZATION_AND_BIOGENESIS	380	12	0.0380181057140847114550475
CCC-001.3	181	2_OXYGEN_BINDING	19	5	0.0385835238727090731880587
CCC-014.4	251	2_NEGATIVE_REGULATION_OF_CELLULAR_METABOLIC_PROCESS	221	18	0.0391687828558350478735939
CCC-016.8	265	2_CARBON_OXYGEN_LYASE_ACTIVITY	22	6	0.0397439704624228118401419
CCC-023.2	39	2_CELLULAR_PROTEIN_METABOLIC_PROCESS	862	13	0.0401712731282992466241843
CCC-018.6	223	2_RESPONSE_TO_STRESS	427	25	0.0405771075655590174324772
CCC-024.5	296	2_CONTRACTILE_FIBER_PART	20	6	0.0406285252703951563213458
CCC-024.5	296	2_MONOOXYGENASE_ACTIVITY	20	6	0.0406285252703951563213458
CCC-014.4	251	2_DNA_DEPENDENT_DNA_REPLICATION	46	8	0.0408278072869231387076461
CCC-023.1	131	1_KEGG_PPAR_SIGNALING_PATHWAY	63	7	0.0411298923358271867334324
CCC-001.3	181	1_KEGG_PPAR_SIGNALING_PATHWAY	63	8	0.0413806192686160465021850
CCC-001.3	181	2_CDC42_PROTEIN_SIGNAL_TRANSDUCTION	10	4	0.0422605439151188672086690
CCC-043.2	332	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	69	11	0.0424599050784661494195582
CCC-023.2	39	2_MACROMOLECULE_BIOSYNTHETIC_PROCESS	217	7	0.0425663404128596711828436
CCC-013.8	242	1_KEGG_DRUG_METABOLISM_CYTOCHROME_P450	48	8	0.0433945472947481411529758
CCC-023.1	131	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	87	8	0.0434405328884209032680452
CCC-026.4	163	1_KEGG_PRION_DISEASES	35	6	0.0435873966678595042845146
CCC-047.8	330	2_REGULATION_OF_BIOLOGICAL_QUALITY	344	28	0.0435989764940834245710022
CCC-026a.1	7	2_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX	11	2	0.0435998655566067136457598
CCC-016.8	265	2_CYTOPLASMIC_PART	912	47	0.0442195047387953926731896
CCC-004.6	237	2_ENZYME_INHIBITOR_ACTIVITY	96	11	0.0446909286573996394897890
CCC-011.2	194	2_MEMBRANE_FRACTION	210	15	0.0446979802524717986789149
CCC-004.6	237	2_REGULATION_OF_PROTEIN_METABOLIC_PROCESS	152	14	0.0452460450685802165193827
CCC-013.8	242	2_STEROL_BINDING	8	4	0.0458145024818323032267386
CCC-013.8	242	2_HISTONE_DEACETYLASE_BINDING	8	4	0.0458145024818323032267386
CCC-023.2	39	2_CELLULAR_MACROMOLECULE_METABOLIC_PROCESS	874	13	0.0465745492251683698703424
CCC-004.6	237	1_KEGG_LINOLEIC_ACID_METABOLISM	25	6	0.0469080496691152842858585
CCC-014.4	251	2_NEGATIVE_REGULATION_OF_METABOLIC_PROCESS	224	18	0.0469519490713303025430925
CCC-025.3	260	2_MICROSOME	23	6	0.0471605443150563963250477
CCC-003.4	381	2_CELLULAR_LIPID_METABOLIC_PROCESS	135	17	0.0479999816396867659551440
CCC-026a.1	7	1_KEGG_DILATED_CARDIOMYOPATHY	90	3	0.0481007984264675836350023
CCC-004.5	2	2_ELECTRON_CARRIER_ACTIVITY	51	2	0.0482828708710605417064876
CCC-052.2	14	1_KEGG_ARACHIDONIC_ACID_METABOLISM	42	3	0.0485725769563158660258040
CCC-052.2	14	2_EXTRACELLULAR_REGION_PART	269	5	0.0493992640899181961744446
CCC-003.4	381	2_RESPONSE_TO_WOUNDING	163	19	0.0495502093508956090173179
CCC-026a.2	94	2_LIPID_BINDING	61	6	0.0498812479354933807629280
CCC-019.10	149	1_KEGG_RETINOL_METABOLISM	39	6	0.0499182699969565116249193
